Search

everythinglearnresearchcommunity

for

Search:↓

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

The study concludes that Twenty-nail dystrophy is more common in boys among children and in women among adults, with varying response to treatment.

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

New treatments for PCOS focus on managing symptoms and improving fertility.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

PCOS is a complex condition linked to hormonal imbalance and insulin resistance, with weight loss being important for management.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

The levonorgestrel intrauterine device for heavy periods may cause acne, hair loss, and excess hair growth.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Most women with excessive hair growth (hirsutism) also experience a common type of non-scarring hair loss called Androgenetic alopecia with telogen effluvium.

The main cause of excessive hair growth in Turkish women is Polycystic ovary syndrome, but in about one fifth of cases, the reason for high male hormone levels is unknown.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.